The customer observed false reactive alinity i toxo igg results for two patients processed on the alinity i serial number (b)(4).The samples were ran on another alinity i and results were nonreactive.The following data was provided: processed (b)(6) 2022, (b)(6), initial result = 0.1 iu/ml repeat 3.6 iu/ml.Processed (b)(6) 2022, (b)(6), initial result = 0.2iu/ml repeat 1.9 iu/ml.Reference range = <1.6 iu/ml = negative 1.6 to < 3.0 iu/ml = gray area = 3.0 iu/ml = positive no impact to patient management was reported.
|
The complaint investigation for false reactive alinity i toxo igg results, using reagent lot number 44254be00, included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and in-house testing.Return testing was not completed as returns were not available.Ticket search by lot indicates that the reagent lot shows slightly higher complaint activity than expected.Ticket review did not identify any trends for the issue for the product.Device history record review did not identify any non-conformances or deviations with lot 44254be00 and the complaint issue.Labeling was reviewed and found to be adequate.In-house testing of a retained reagent kit of the complaint lot was performed.All specifications were met, and no false reactive results were obtained, showing that the lot generates the expected results.Based on our investigation, no systemic issue or deficiency with the alinity i toxo igg reagent for lot 44254be00 was identified.Corrected data in section h4 device mfg date to 09/15/2022 from 05/15/2022.
|